Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04896645 · ClinicalTrials.gov registry record · NA
Albuterol Integrated Adherence Monitoring in Children With Asthma
A NA study, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT04896645 is a NA study that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 21 participants.
The verdict
NCT04896645, a NA study, has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The investigators propose to evaluate whether an integrated electronic adherence monitoring albuterol rescue inhaler can improve proper use in a mostly minority and inner-city population of children treated for asthma at the Children's Hospital of Los Angeles
Interventions
- DEVICE Digihaler Albuterol Device by TEVA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2022-06-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04896645
The ClinicalTrials.gov registry entry for NCT04896645 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Digihaler Albuterol Device by TEVA is the first listed.
NCT04896645 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04896645 about?
NCT04896645 is a clinical study titled "Albuterol Integrated Adherence Monitoring in Children With Asthma". The investigators propose to evaluate whether an integrated electronic adherence monitoring albuterol rescue inhaler can improve proper use in a mostly minority and inner-city population of children treated for asthma at the Children's Hospital of Los Angeles
What is the current status of trial NCT04896645?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2021-06-01. Estimated completion is 2022-06-22.
What interventions are being tested in trial NCT04896645?
The interventions under investigation include: Digihaler Albuterol Device by TEVA (DEVICE).
Who is sponsoring clinical trial NCT04896645?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.